Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PRONESTYL

PROCAINAMIDE HYDROCHLORIDE

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PRONESTYL is listed in Drugs@FDA under application 017371 (NDA).

Marketing status: Discontinued Active ingredient PROCAINAMIDE HYDROCHLORIDE Form and strength TABLET;ORAL - 250MG Sponsor APOTHECON Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview PRONESTYL is listed in Drugs@FDA under application 017371 (NDA). Marketing status: Discontinued Active ingredient PROCAINAMIDE HYDROCHLORIDE Form and strength TABLET;ORAL - 250MG Sponsor APOTHECON Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.